Liver-targeting Resibufogenin-loaded poly(lactic-co-glycolic acid)-d-α-tocopheryl polyethylene glycol 1000 succinate nanoparticles for liver cancer therapy

References

• El-SeragHBHepatocellular carcinoma: an epidemiologic viewJ Clin Gastroenterol200235Suppl 2S72S7812394209
   PubMedGoogle Scholar
• MarkusPRDrug therapy for advanced-stage liver cancerLiver Cancer2014312513110.1159/00034386824945003
   PubMedGoogle Scholar
• LiuJQianLXTherapeutic efficacy comparison of radiofrequency ablation in hepatocellular carcinoma and metastatic liver cancerExp Ther Med20147489790010.3892/etm.2014.150524669247
   PubMedGoogle Scholar
• LiDKangJMadoffDCLocally ablative therapies for primary and metastatic liver cancerExpert Rev Anticancer Ther201414893194510.1586/14737140.2014.91109124746315
   PubMed Web of Science ®Google Scholar
• BaekYHKimKTLeeSWEfficacy of hepatic arterial infusion chemotherapy in advanced hepatocellular carcinomaWorld J Gastroenterol2012182634263434 doi: wjg.v18.i26.342622807613
   PubMedGoogle Scholar
• ZhangDMLiuJSDengLJArenobufagin, a natural bufadienolide from toad venom, induces apoptosis and autophagy in human hepatocellular carcinoma cells through inhibition of PI3K/Akt/mTOR pathwayCarcinogenesis20133461331134210.1093/carcin/bgt06023393227
   PubMed Web of Science ®Google Scholar
• QiuDZZhangZJWuWZYangYKBufalin, a component in Chansu, inhibits proliferation and invasion of hepatocellular carcinoma cellsBMC Complement Altern Med20131318510.1186/1472-6882-13-18523870199
   PubMed Web of Science ®Google Scholar
• The State Pharmacopoeia Commission of People’s Republic of ChinaPharmacopoeia of People’s Republic of China1BeijingChemical Industry Press2010360
   Google Scholar
• KamanoYKotakeAHashimaHStructure-cytotoxic activity relationship for the toad poison bufadienolidesBioorg Med Chem1998671103111510.1016/S0968-0896(98)00067-49730247
   PubMedGoogle Scholar
• MaXCXinXLLiuKXHanJGuoDAMicrobial transformation of cinobufagin by Syncephalastrum racemosumJ Nat Prod20087171268127010.1021/np800210a18558746
   PubMedGoogle Scholar
• LiLLiPYeMZhongLGuoDCytotoxic Resibufogenin transformation products from cell suspension cultures of Platycodon grandiflorumLett Org Chem20041217617810.2174/1570178043488509
   Google Scholar
• BickRJPoindexterBJSweneyRRDasguptaAEffects of Chan Su, a traditional Chinese medicine, on the calcium transients of isolated cardiomyocytes: cardiotoxicity due to more than Na, K-ATPase blockingLife Sci200272669970910.1016/S0024-3205(02)02302-012467910
   PubMed Web of Science ®Google Scholar
• XieJTDeyLWuJALowellTKYuanCSCardiac toxicity of resibufogenin: electrophysiological evidenceActa Pharmacol Sin200122428929711742580
   PubMedGoogle Scholar
• WangXYangLChenZGShinDMApplication of nanotechnology in cancer therapy and imagingCA Cancer J Clin20085829711010.3322/CA.2007.000318227410
   PubMed Web of Science ®Google Scholar
• ChakrabortyMJainSRaniVNanotechnology: emerging tool for diagnostics and therapeuticsAppl Biochem Biotechnol20111655–61178118710.1007/s12010-011-9336-621847590
   PubMedGoogle Scholar
• JainRAThe manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devicesBiomaterials200021232475249010.1016/S0142-9612(00)00115-011055295
   PubMed Web of Science ®Google Scholar
• ZimmerAKreuterJMicrospheres and nanoparticles used in ocular delivery systemsAdv Drug Deliv Rev199516617310.1016/0169-409X(95)00017-2
   Web of Science ®Google Scholar
• FengSSMeiLAnithaPGanCWZhouWPoly(lactide)–vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of DocetaxelBiomaterials2009303297330610.1016/j.biomaterials.2009.02.04519299012
   PubMed Web of Science ®Google Scholar
• MaYZhengYLiuKNanoparticles of poly (lactide-co-glycolide)-d-a-tocopheryl polyethylene glycol 1000 succinate random copolymer for cancer treatmentNanoscale Res Lett2010571161116910.1007/s11671-010-9620-320596457
   PubMedGoogle Scholar
• ChenHBZhengYTianGOral delivery of DMAB-modified docetaxel-loaded PLGA-TPGS nanoparticles for cancer chemotherapyNanoscale Res Lett201161410.1007/s11671-010-9741-8
   PubMedGoogle Scholar
• FischerJRHarkinKRFreemanLCConcurrent administration of water-soluble vitamin E can increase the oral bioavailability of cyclosporine a in healthy dogsVet Ther20023446547312584684
   PubMedGoogle Scholar
• MeiLZhangYZhengYA novel docetaxel-loaded poly (ε-caprolactone)/pluronic F68 nanoparticle overcoming multidrug resistance for breast cancer treatmentNanoscale Res Lett20094121530153910.1007/s11671-009-9431-620652101
   PubMed Web of Science ®Google Scholar
• MukerjeeAVishwanathaJKFormulation, characterization and evaluation of curcumin-loaded PLGA nanospheres for cancer therapyAnticancer Res200929103867387619846921
   PubMed Web of Science ®Google Scholar
• LeoECameroniRForniFDynamic dialysis for the drug release evaluation from doxorubicin-gelatin nanoparticle conjugatesInt J Pharm19991801233010.1016/S0378-5173(98)00401-310089288
   PubMedGoogle Scholar
• WinKYFengSSEffects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugsBiomaterials200526152713272210.1016/j.biomaterials.2004.07.05015585275
   PubMed Web of Science ®Google Scholar
• ZhuZLiYLiXPaclitaxel-loaded poly (N-vinylpyrrolidone)-b-poly(ε-caprolactone) nanoparticles: preparation and antitumor activity in vivoJ Control Release2010142343844610.1016/j.jconrel.2009.11.00219896997
   PubMed Web of Science ®Google Scholar
• FengSSZhaoLZhangZChemotherapeutic engineering: vitamin E TPGS-emulsified nanoparticles of biodegradable polymers realized sustainable paclitaxel chemotherapy for 168 h in vivoChem Eng Sci200762236641664810.1016/j.ces.2007.08.006
   Google Scholar
• PerraultSDWalkeyCJenningsTFischerHCChanWCMediating tumor targeting efficiency of nanoparticles through designNano Lett2009951909191510.1021/nl900031y19344179
   PubMed Web of Science ®Google Scholar
• FlorenceATNanoparticle uptake by the oral route: fulfilling its potential?Drug Discov Today Technol200521758110.1016/j.ddtec.2005.05.01924981758
   PubMedGoogle Scholar
• NorrisDAPuriNSinkoPJThe effect of physical barriers and properties on the oral absorption of particulatesAdv Drug Deliv Rev1998342–313515410.1016/S0169-409X(98)00037-410837675
   PubMed Web of Science ®Google Scholar
• ZhangZRHeQStudy on liver targeting and hepatocytes permeable valaciclovir polybutylcyanoacrylate nanoparticlesWorld J Gastroenterol19995433033311819460
   PubMedGoogle Scholar
• OwensDE3rdPeppasNAOpsonization, biodistribution, and pharmacokinetics of polymeric nanoparticlesInt J Pharm200630719310210.1016/j.ijpharm.2005.10.01016303268
   PubMed Web of Science ®Google Scholar
• ChoCSKobayashiATakeiRIshiharaTMaruyamaAAkaikeTReceptor-mediated cell modulator delivery to hepatic using nanoparticles coated with carbohydrate-carrying polymersBiomaterials2001221455111085382
   PubMedGoogle Scholar
• KloseDDelplaceCSiepmannJUnintended potential impact of perfect sink conditions on PLGA degradation in microparticlesInt J Pharm20114041–2758210.1016/j.ijpharm.2010.10.05421056644
   PubMedGoogle Scholar
• ZhuHChenHZengXCo-delivery of chemotherapeutic drugs with vitamin E TPGS by porous PLGA nanoparticles for enhanced chemotherapy against multi-drug resistanceBiomaterials20143572391240010.1016/j.biomaterials.2013.11.08624360574
   PubMed Web of Science ®Google Scholar